Familial hypocalciuric hypercalcemia epidemiology and demographics: Difference between revisions
(→Age) |
|||
Line 14: | Line 14: | ||
===Age=== | ===Age=== | ||
Patients of all age groups may develop familial hypocalciuric hypercalcemia. | |||
===Race=== | ===Race=== |
Revision as of 20:47, 25 September 2017
Familial hypocalciuric hypercalcemia Microchapters |
Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Familial hypocalciuric hypercalcemia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia epidemiology and demographics |
FDA on Familial hypocalciuric hypercalcemia epidemiology and demographics |
CDC on Familial hypocalciuric hypercalcemia epidemiology and demographics |
Familial hypocalciuric hypercalcemia epidemiology and demographics in the news |
Blogs on Familial hypocalciuric hypercalcemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
The prevalence of FHH is estimated to be 1 in 78,000 hypercalcemia cases[1].
Age
Patients of all age groups may develop familial hypocalciuric hypercalcemia.
Race
- There is incomplete evidence regarding the racial predilection to familial hypocalciuric hypercalcemia.
Gender
- FHH affects men and women equally.
References
- ↑ Hinnie J, Bell E, McKillop E, Gallacher S (2001). "The prevalence of familial hypocalciuric hypercalcemia". Calcif. Tissue Int. 68 (4): 216–8. doi:10.1007/s002230001201. PMID 11353947.